SAYER KEVIN R (President & CEO) sold 8.1% of their position (26.76K shares) of DEXCOM INC on the open market
Open‑market sale worth $2.41M — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 8/24/2026ACC: 0001093557-26-000151
DirectorOfficer· President & CEO
Since Jul 2018
-26.76K
Net shares
Net seller
$2.41M
Total sold
3
Open market trades
0B · 3S
3
Total transactions
26.76K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−19.31K
Price / share
$89.71
Trade value
$1.73M
% of position
5.9%
8/20/2026
328.97K→309.66K
Common Stock
Direct
Shares
−7.35K
Price / share
$90.78
Trade value
$667.33K
% of position
2.4%
8/20/2026
309.66K→302.31K
Common Stock
Direct
Shares
−97.00
Price / share
$91.41
Trade value
$8.87K
% of position
0.0%
8/20/2026
302.31K→302.21K
Total
Net shares
−26.76K
Net value
-$2.41M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/20/2026 | S · Sale | −19.31K | $89.71 | $1.73M | 5.9% | 328.97K | 309.66K |
| Common Stock Direct | 8/20/2026 | S · Sale | −7.35K | $90.78 | $667.33K | 2.4% | 309.66K | 302.31K |
| Common Stock Direct | 8/20/2026 | S · Sale | −97.00 | $91.41 | $8.87K | 0.0% | 302.31K | 302.21K |
| Total | −26.76K | -$2.41M | ||||||
Derivative Transactions0
No derivative transactions reported